Preferred Label : enprostil;
MeSH definition : A synthetic PGE2 analog that has an inhibitory effect on gastric acid secretion, a
mucoprotective effect, and a postprandial lowering effect on gastrin. It has been
shown to be efficient and safe in the treatment of gastroduodenal ulcers.;
MeSH hyponym : gardrin; RS-84135; RS 84135; RS84135;
Related MeSH term : enprostil, (1alpha(R*),2beta(1E,3S*),3alpha)-( -)-Isomer; enprostil, (1alpha,2beta(1E,3R*),3alpha)-( -)-Isomer; enprostil, (1R-(1alpha,2beta(1E,3R*),3alpha))-Isomer; enprostil, (1S-(1alpha(S*),2beta(1E,3R*),3alpha))-Isomer; enprostil, (1S-(1alpha(R*),2beta(1E,3R*),3alpha))-Isomer; enprostil, (1R-(1alpha(S*),2beta(1E,3R*),3alpha))-Isomer; enprostil, (1R-(1(R*),2beta(1E,3R*),3alpha))-Isomer; enprostil, (1alpha(R*),2beta(1E,3R*),3alpha)-( -)-Isomer; enprostil, (1alpha,2alpha(1E,3S*),3beta)-( -)-Isomer;
MeSH CAS label : 4,5-Heptadienoic acid, 7-(3-hydroxy-2-(3-hydroxy-4-phenoxy-1-butenyl)-5-oxocyclopentyl)-,
methyl ester, (1alpha,2beta(1E,3R*),3alpha)-;
MeSH Related Number : enprostil, (1R-(1alpha(S*),2beta(1E,3R*),3alpha))-Isomer; enprostil, (1R-(1alpha,2beta(1E,3R*),3alpha))-Isomer; enprostil, (1S-(1alpha(R*),2beta(1E,3R*),3alpha))-Isomer; enprostil, (1S-(1alpha(S*),2beta(1E,3R*),3alpha))-Isomer; enprostil, (1alpha(R*),2beta(1E,3R*),3alpha)-( -)-Isomer; enprostil, (1R-(1(R*),2beta(1E,3R*),3alpha))-Isomer; enprostil, (1alpha(R*),2beta(1E,3S*),3alpha)-( -)-Isomer; enprostil, (1alpha,2alpha(1E,3S*),3beta)-( -)-Isomer; enprostil, (1alpha,2beta(1E,3R*),3alpha)-( -)-Isomer; 73121-56-9 (Enprostil); 105368-46-5; 105368-47-6; 108815-44-7; 108815-47-0; 125638-68-8; 82444-04-0; 93000-00-1; 99631-10-4; 99631-11-5;
Registry Number MeSH : 73121-56-9;
Related CAS MeSH : 108815-47-0 (Enprostil, (1alpha(R*),2beta(1E,3S*),3alpha)-( -)-Isomer); 125638-68-8 (Enprostil, (1alpha,2alpha(1E,3S*),3beta)-( -)-Isomer); 82444-04-0 (Enprostil, (1alpha,2beta(1E,3R*),3alpha)-( -)-Isomer); 99631-10-4 (Enprostil, (1R-(1alpha(S*),2beta(1E,3R*),3alpha))-Isomer); 93000-00-1 (Enprostil, (1R-(1alpha,2beta(1E,3R*),3alpha))-Isomer); 105368-47-6 (Enprostil, (1S-(1alpha(R*),2beta(1E,3R*),3alpha))-Isomer); 105368-46-5 (Enprostil, (1S-(1alpha(S*),2beta(1E,3R*),3alpha))-Isomer); 108815-44-7 (Enprostil, (1alpha(R*),2beta(1E,3R*),3alpha)-( -)-Isomer); 99631-11-5 (Enprostil, (1R-(1(R*),2beta(1E,3R*),3alpha))-Isomer);
Wikipedia link : https://en.wikipedia.org/wiki/Enprostil;
Is substance : O;
UNII : J4IP5Z9DAU;
InChIKey : PTOJVMZPWPAXER-FPXSIRDUSA-N;
Origin ID : D016620;
UMLS CUI : C0085191;
ATC code(s)
Allowable qualifiers
Currated CISMeF NLP mapping
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
A synthetic PGE2 analog that has an inhibitory effect on gastric acid secretion, a
mucoprotective effect, and a postprandial lowering effect on gastrin. It has been
shown to be efficient and safe in the treatment of gastroduodenal ulcers.